{"id":388587,"date":"2020-11-25T10:03:24","date_gmt":"2020-11-25T15:03:24","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=388587"},"modified":"2020-11-25T10:03:24","modified_gmt":"2020-11-25T15:03:24","slug":"avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\/","title":{"rendered":"Avivagen Announces Expansion of Non-Dilutive Financing in Support of Increased Product Sales"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Avivagen Announces Expansion of Non-Dilutive Financing in Support of Increased Product Sales<\/b><\/p>\n<p>OTTAWA, Ontario&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nAvivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (\u201cAvivagen\u201d or the \u201cCorporation\u201d), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and performance, announces that given the recent significant ramp up in placed orders for its OxC-beta Livestock\u2122 and the upcoming launch of its human nutraceutical product, it has obtained additional debt financing of $350,000 through an unsecured Promissory Note from a Canadian Financial Institution. The financing is in addition to the $500,000 borrowed from the same lender on the same terms in October 2020.\n<\/p>\n<p>\nThe note is payable on demand and bears interest at 12% per annum. The funds will be used to support ongoing general operating activities which include, but are not limited to, the ramp up in inventory in support of increasing frequency and size of orders for OxC-beta Livestock\u2122.\n<\/p>\n<p><b>About Avivagen<\/b><\/p>\n<p>\nAvivagen is a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications. By unlocking an overlooked facet of \u03b2-carotene activity, a path has been opened to safely and economically support immune function, thereby promoting general health and performance in animals. Avivagen is a public corporation traded on the TSX Venture and OTCQB\u00ae Venture Market exchanges under the symbols VIV and VIVXF, and is headquartered in Ottawa, Canada, based in partnership facilities of the National Research Council of Canada and Charlottetown, Prince Edward Island. For more information, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.avivagen.com&amp;esheet=52336906&amp;newsitemid=20201125005668&amp;lan=en-US&amp;anchor=www.avivagen.com&amp;index=1&amp;md5=db29d1237c3106edb321c838cbb4facc\">www.avivagen.com<\/a>. The contents of the website are expressly not incorporated by reference in this press release.\n<\/p>\n<p><b>About OxC-beta\u2122 Technology and OxC-beta\u2122 Livestock<\/b><\/p>\n<p>\nAvivagen\u2019s OxC-beta\u2122 technology is derived from Avivagen discoveries about \u03b2-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colours. Through support of immune function the technology provides a non-antibiotic means of promoting health and growth. OxC-beta\u2122 Livestock is a proprietary product shown to be an effective and economic alternative to the antibiotics commonly added to livestock feeds. The product is currently available for sale in the United States, Philippines, Taiwan, New Zealand, Thailand, Mexico, Brazil, Australia and Malaysia.\n<\/p>\n<p>\nAvivagen\u2019s OxC-beta\u2122 Livestock product is safe, effective and could fulfill the global mandate to remove all in-feed antibiotics as growth promoters. Numerous international livestock trials with poultry and swine using OxC-beta\u2122 Livestock have proven that the product performs as well as, and, sometimes, in some aspects, better than in-feed antibiotics.\n<\/p>\n<p style=\"font-weight:normal\"><b>Forward Looking Statements<\/b><\/p>\n<p><i>This news release includes certain forward-looking statements that are based upon the current expectations of management. Forward-looking statements involve risks and uncertainties associated with the business of Avivagen Inc. and the environment in which the business operates. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking, including those identified by the expressions \u201caim\u201d, \u201canticipate\u201d, \u201cappear\u201d, \u201cbelieve\u201d, \u201cconsider\u201d, \u201ccould\u201d, \u201cestimate\u201d, \u201cexpect\u201d, \u201cif\u201d, \u201cintend\u201d, \u201cgoal\u201d, \u201chope\u201d, \u201clikely\u201d, \u201cmay\u201d, \u201cplan\u201d, \u201cpossibly\u201d, \u201cpotentially\u201d, \u201cpursue\u201d, \u201cseem\u201d, \u201cshould\u201d, \u201cwhether\u201d, \u201cwill\u201d, \u201cwould\u201d and similar expressions. Statements set out in this news release relating to the possibility for OxC-beta\u2122 Livestock to replace antibiotics in livestock feeds as growth promoters are forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. For instance, Avivagen\u2019s products may not gain market acceptance or regulatory approval in new jurisdictions or for new applications and may not be widely accepted as a replacement for antibiotics as growth promoters in livestock feeds due to many factors, many of which are outside of Avivagen\u2019s control. Readers are referred to the risk factors associated with the business of Avivagen set out in Avivagen\u2019s most recent management\u2019s discussion and analysis of financial condition available at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.SEDAR.com&amp;esheet=52336906&amp;newsitemid=20201125005668&amp;lan=en-US&amp;anchor=www.SEDAR.com&amp;index=2&amp;md5=55fe47f13d7ee0fd1631820cf0c4fe97\">www.SEDAR.com<\/a>. Except as required by law, Avivagen assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements.<\/i><\/p>\n<p><i>Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.<\/i><\/p>\n<p>\nCopyright \u00a9 2020 Avivagen Inc. OxC-beta\u2122 is a trademark of Avivagen Inc.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201125005668r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20201125005668\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20201125005668\/en\/<\/a><\/span><\/p>\n<p>\nAvivagen Inc.<br \/>\n<br \/>Drew Basek<br \/>\n<br \/>Director of Investor Relations<br \/>\n<br \/>100 Sussex Drive, Ottawa, Ontario, Canada K1A 0R6<br \/>\n<br \/>Phone: 416-540-0733<br \/>\n<br \/>E-mail: <a rel=\"nofollow\" href=\"mailto:d.basek@avivagen.com\">d.basek@avivagen.com<\/a><\/p>\n<p>\nKym Anthony<br \/>\n<br \/>Chief Executive Officer<br \/>\n<br \/>100 Sussex Drive, Ottawa, Ontario, Canada K1A 0R6 Head Office<br \/>\n<br \/>Phone: 613-949-8164<br \/>\n<br \/>Website: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.avivagen.com%2F&amp;esheet=52336906&amp;newsitemid=20201125005668&amp;lan=en-US&amp;anchor=www.avivagen.com&amp;index=3&amp;md5=0bed4fd6abc23d4ef8011718e704e14e\">www.avivagen.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> North America Canada<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Health General Health Other Natural Resources Pharmaceutical Pets Agriculture Other Science Natural Resources Consumer Science Veterinary<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\" \/>\n","protected":false},"excerpt":{"rendered":"<p>Avivagen Announces Expansion of Non-Dilutive Financing in Support of Increased Product Sales OTTAWA, Ontario&#8211;(BUSINESS WIRE)&#8211; Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (\u201cAvivagen\u201d or the \u201cCorporation\u201d), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and performance, announces that given the recent significant ramp up in placed orders for its OxC-beta Livestock\u2122 and the upcoming launch of its human nutraceutical product, it has obtained additional debt financing of $350,000 through an unsecured Promissory Note from a Canadian Financial Institution. The financing is in addition to the $500,000 borrowed from the same lender on the same terms in October 2020. The note is payable on &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Avivagen Announces Expansion of Non-Dilutive Financing in Support of Increased Product Sales&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-388587","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Avivagen Announces Expansion of Non-Dilutive Financing in Support of Increased Product Sales - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Avivagen Announces Expansion of Non-Dilutive Financing in Support of Increased Product Sales - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Avivagen Announces Expansion of Non-Dilutive Financing in Support of Increased Product Sales OTTAWA, Ontario&#8211;(BUSINESS WIRE)&#8211; Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (\u201cAvivagen\u201d or the \u201cCorporation\u201d), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and performance, announces that given the recent significant ramp up in placed orders for its OxC-beta Livestock\u2122 and the upcoming launch of its human nutraceutical product, it has obtained additional debt financing of $350,000 through an unsecured Promissory Note from a Canadian Financial Institution. The financing is in addition to the $500,000 borrowed from the same lender on the same terms in October 2020. The note is payable on &hellip; Continue reading &quot;Avivagen Announces Expansion of Non-Dilutive Financing in Support of Increased Product Sales&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-25T15:03:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201125005668r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Avivagen Announces Expansion of Non-Dilutive Financing in Support of Increased Product Sales\",\"datePublished\":\"2020-11-25T15:03:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\\\/\"},\"wordCount\":807,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201125005668r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\\\/\",\"name\":\"Avivagen Announces Expansion of Non-Dilutive Financing in Support of Increased Product Sales - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201125005668r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2020-11-25T15:03:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201125005668r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201125005668r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Avivagen Announces Expansion of Non-Dilutive Financing in Support of Increased Product Sales\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Avivagen Announces Expansion of Non-Dilutive Financing in Support of Increased Product Sales - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\/","og_locale":"en_US","og_type":"article","og_title":"Avivagen Announces Expansion of Non-Dilutive Financing in Support of Increased Product Sales - Market Newsdesk","og_description":"Avivagen Announces Expansion of Non-Dilutive Financing in Support of Increased Product Sales OTTAWA, Ontario&#8211;(BUSINESS WIRE)&#8211; Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (\u201cAvivagen\u201d or the \u201cCorporation\u201d), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and performance, announces that given the recent significant ramp up in placed orders for its OxC-beta Livestock\u2122 and the upcoming launch of its human nutraceutical product, it has obtained additional debt financing of $350,000 through an unsecured Promissory Note from a Canadian Financial Institution. The financing is in addition to the $500,000 borrowed from the same lender on the same terms in October 2020. The note is payable on &hellip; Continue reading \"Avivagen Announces Expansion of Non-Dilutive Financing in Support of Increased Product Sales\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-25T15:03:24+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201125005668r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Avivagen Announces Expansion of Non-Dilutive Financing in Support of Increased Product Sales","datePublished":"2020-11-25T15:03:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\/"},"wordCount":807,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201125005668r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\/","name":"Avivagen Announces Expansion of Non-Dilutive Financing in Support of Increased Product Sales - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201125005668r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2020-11-25T15:03:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201125005668r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201125005668r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/avivagen-announces-expansion-of-non-dilutive-financing-in-support-of-increased-product-sales\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Avivagen Announces Expansion of Non-Dilutive Financing in Support of Increased Product Sales"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/388587","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=388587"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/388587\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=388587"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=388587"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=388587"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}